Ariosa Diagnostics, Inc.
5945 Optical Court
San Jose
California
95138
United States
Tel: 408-229-7500
Website: http://www.ariosadx.com/
50 articles about Ariosa Diagnostics, Inc.
-
Illumina Wins Infringement Suit Against Ariosa Diagnostics, Inc.
6/17/2019
Illumina, Inc. (NASDAQ: ILMN) announced today that the High Court of Justice, Chancery Division, Patents Court in the United Kingdom issued a judgment in its favor in the patent infringement suit filed against Ariosa Diagnostics, Inc.
-
The US Patent and Trademark Office previously upheld the validity of the patents rejecting multiple challenges filed by Ariosa.
-
Illumina Wins Infringement Suit Against Premaitha Health and Ariosa Diagnostics
11/22/2017
The Court found that Premaitha’s IONA test infringed EP 1 981 995, EP 2 385 143, EP 2 183 693 and EP 2 514 842, which are generally directed to the use of sequencing in non-invasive prenatal testing (NIPT).
-
Ariosa Diagnostics Release: New publication Shows Consistent Clinical Performance In Screening Common Fetal Trisomies With Harmony Prenatal Test
11/3/2015
-
Ariosa Diagnostics' Harmony Prenatal Test Now Performed In Australia And United Kingdom At Sonic Healthcare Laboratories
10/13/2015
-
Ariosa Diagnostics Wins CE Mark For Its FORTE Software To Support Harmony Prenatal Test
6/11/2015
-
Illumina Files New Patent Infringement Suit Against Ariosa Diagnostics, Inc. And Roche Molecular Systems, Inc.
5/19/2015
-
Ariosa Diagnostics, Inc.'s Harmony Prenatal Test Shown To Be Superior To Conventional Pregnancy Screening For Down Syndrome (Trisomy 21) In Largest Clinical Trial
4/2/2015
-
Down Syndrome Detection Company Ariosa Diagnostics, Inc. Officially Withdraws IPO; Acquired by Roche
1/14/2015
-
Roche Acquires Ariosa Diagnostics, Inc. And Enters The Non-Invasive Prenatal Test (NIPT) And Cell-Free DNA Testing Services Markets
12/3/2014
-
Affymetrix (Santa Clara, California) And Ariosa Diagnostics, Inc. Announce Signing Of Multi-Year Supply Agreement In Support Of Ariosa’s Non-Invasive Prenatal Test
10/16/2014
-
Ariosa Diagnostics, Inc. Receives Conditional Approval From New York State Department Of Health For Harmony Prenatal Test In All Pregnant Women
5/6/2014
-
Ariosa Diagnostics, Inc. Welcomes New Board Member Kate Falberg
4/30/2014
-
Illumina, Inc. Files New Patent Infringement Suit Against Ariosa Diagnostics, Inc.
4/28/2014
-
San Jose's Ariosa Diagnostics, Inc. Takes Pre-Natal Genetic Test To Wall Street, Eyes $69 Million IPO
3/26/2014
-
Ariosa Diagnostics, Inc. Shows Continued Growth Of The Harmony™ Prenatal Test In Fourth Quarter Of 2013 And Obtains CPT Code
3/14/2014
-
Ariosa Diagnostics, Inc. Secures New York Lab Licensure Approval For The Harmony Prenatal Test
2/12/2014
-
Ariosa Diagnostics, Inc. and Sonic Healthcare Ltd. Germany Laboratories Announce New Partnership To Offer Pregnant Women The Harmony Prenatal Test In Germany
12/6/2013
-
Ariosa Diagnostics, Inc. Provides Harmony Prenatal Test To Over 40,000 Women And Expands Into More Than 50 Countries In The Third Quarter Of 2013
11/13/2013
-
Ariosa Diagnostics, Inc. Appoints Dan Puckett as Chief Financial Officer and Dr. Thomas Musci as Chief Medical Officer
11/7/2013